🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study aim is comparison of heart failire with preserved ejection fraction (...
Status
Recruiting
Location
Kazan State Medical University
Start Date
2026-01-01
Trial ID
NCT07375433
Stress (Takotsubo) cardiomyopathy (SC) is a peculiar form of acute, reversi...
Status
Terminated
Location
University of Missouri
Start Date
2009-08
Trial ID
NCT01048125
Background: Stress echocardiography (SE) has an established role in evidenc...
Status
Unknown
Location
Fatebenefratelli Hospital
Start Date
2016-11
Trial ID
NCT03049995
The goal of this study is to evaluate cardiovascular effects of long-acting...
Status
Active Not Recruiting
Location
Alexandra General Hospital of Athens
Start Date
2026-04-01
Trial ID
NCT07707479
Treatments Being Tested
Hereditary haemochromatosis (HHC) is a frequent disease in Brittany (5 to 7...
Status
Completed
Location
Rennes University Hospital
Start Date
2014-11-05
Trial ID
NCT02099214
Left ventricular obstruction is an invalidating complication of hypertrophi...
Status
Completed
Location
University Hospital, Bordeaux
Start Date
2019-10-22
Trial ID
NCT04129905
The study will evaluate myocardial inflammation in cyclists after high inte...
Status
Completed
Location
Jessa Hospital
Start Date
2021-07-01
Trial ID
NCT05138003
With stress echo (SE) 2020 study, a new standard of practice in stress imag...
Status
Recruiting
Location
Fatebenefratelli Hospital
Start Date
2021-04-01
Trial ID
NCT05081115
The purpose of this study to find out whether an intensive approach to trea...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2023-08-18
Trial ID
NCT06023576
The combination of epirubicin-cyclophosphamide (EC) and paclitaxel (Tax) is...
Status
Terminated
Location
Institut de cancérologie Strasbourg Europe
Start Date
2023-09-21
Trial ID
NCT05803889
Treatments Being Tested